Assessment of the adherence of cardiologists to guidelines for the treatment of atrial fibrillation;Avaliação do conhecimento dos cardiologistas sobre diretrizes do tratamento da fibrilação atrial

Arquivos Brasileiros de Cardiologia

Volumn 101, Issue 2, 2013, Pages 127-133

  van der Sand, Cézar R ^a   Leiria, Tiago Luiz Luz ^a   Kalil, Renato Abdala Karam ^a  

^a INSTITUTO DE CARDIOLOGIA DO RIO GRANDE DO SUL   (Brazil)

Author keywords

Anticoagulants; Atrial fibrillation; Guidelines

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DABIGATRAN; DIGOXIN; PROPAFENONE; WARFARIN;

ABLATION THERAPY; ADULT; AGED; ANTICOAGULATION; ARTICLE; BRAIN HEMORRHAGE; CARDIOLOGIST; CARDIOVERSION; CROSS-SECTIONAL STUDY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HUMAN; KNOWLEDGE; MALE; PRACTICE GUIDELINE; PROTHROMBIN TIME; PROTOCOL COMPLIANCE; QUESTIONNAIRE; RISK ASSESSMENT; SCORING SYSTEM;

ADULT; ATRIAL FIBRILLATION; BRAZIL; CARDIOLOGY; CLINICAL COMPETENCE; CROSS-SECTIONAL STUDIES; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES; SOCIETIES, MEDICAL; TIME FACTORS;

EID: 84884138849     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.5935/abc.20130148     Document Type: Article

References (25)

1. Mion D Jr, da Silva GV, de Gusmão JL, Machado CA, Amodeo C, Nobre F, et al. Os médicos brasileiros seguem as diretrizes brasileiras de hipertensão? ArqBrasCardiol.2007;88(2):212-7.
2. Grol R, Dalhuijsen J, Thomas S, Veld C, Rutten G, Mokkink H. Attributesofclinicalguidelinesthatinfluence use ofguidelines in general practice: observationalstudy. BMJ.1998;317(7162):858-61.
3. Lugtenberg M, Zegers-van Schaick JM, Westert GP, Burgers JS. Why don't physicians adhere to guideline recommendations in practice? An analysis of barriers among Dutch general practitioners. Implement Sci. 2009;4:54.
4. Burgers JS, Grol RP, Zaat JO, Spies TH, van der Bij AK, Mokkink HG. Characteristics of effective clinical guidelines for general practice. Br J Gen Pract. 2003;53(486):15-9.
5. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation: analysisand implications. Arch Intern Med. 1995;155(5):469-73.
6. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114(2):119-25.
7. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort: The Framingham Heart Study. JAMA. 1994;271(11):840-4.
8. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al; American CollegeofCardiology/American Heart AssociationTask Force onPracticeGuidelines; EuropeanSocietyofCardiologyCommittee for PracticeGuidelines; EuropeanHeart RhythmAssociation; Heart RhythmSociety. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114(7):e257-354. Erratum in Circulation. 2007;116(6):e138.
9. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al;European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31(19):2369-429. Erratum in Eur Heart J. 2011;32(9):1172.
10. Cairns JA, Connolly S, McMurtry S, Stephenson M, Talajic M; CCS Atrial Fibrillation Guidelines Committee. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter. Can J Cardiol. 2011;27(1):74-90.
11. Zimerman LI, Fenelon G, Martinelli Filho M, Grupi C, Atié J, Lorga Filho A, et al; Sociedade Brasileira de Cardiologia. Diretrizes brasileiras de fibrilação atrial. ArqBrasCardiol. 2009;92(6 supl. 1):1-39.
12. Sass N, Torloni MR, Soares BG, Atallah AN. Continuing medical education in Brazil: what about obstetricians and gynecologists? Sao Paulo Med J.2005;123(1):5-10.
13. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: resultsfrom the National Registryof Atrial Fibrillation. JAMA. 2001;285(22):2864-70.
14. Olesen JB, Lip GY, Hansen ML, Hansen PR, Tolstrup JS, Lindhardsen J, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ. 2011;342:d124.
15. Meinertz T, Kirch W, Rosin L, Pittrow D, Willich SN, Kirchhof P; ATRIUM investigators. Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry. Clin Res Cardiol. 2011;100(10):897-905.
16. Leiria TL, Lopes RD, Williams JB, Katz JN, Kalil RA, Alexander JH. Antithrombotic therapies in patients with prosthetic heart valves: guidelines translated for the clinician. J Thromb Thrombolysis. 2011;31(4):514-22.
17. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al;European Heart Rhythm Association; Heart Rhythm Society, ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am CollCardiol. 2006;48(5):e247-346.
18. Leiria TL, Pellanda L, Miglioranza MH, Sant'anna RT, Becker LS, Magalhães E, et al. [Warfarin and phenprocoumon: experience of an outpatient anticoagulation clinic]. Arq Bras Cardiol. 2010;94(1):41-5.
19. Esmerio FG, Souza EN, Leiria TL, Lunelli R, Moraes MA. Constant use of oral anticoagulants: implications in the control of their adequate levels. Arq Bras Cardiol. 2009;93(5):549-54.
20. deLima GG, Kalil RA, Leiria TL, Hatem DM, Kruse CL, Abrahão R, et al. Randomized study of surgery for patients with permanent atrial fibrillation as a result of mitral valve disease. Ann Thorac Surg. 2004;77(6):2089-94.
21. Ulimoen SR, Enger S, Carlson J, Platonov PG, Pripp AH, Abdelnoor M, et al. Comparison of four single-drug regimens on ventricular rate and arrhythmia-related symptoms in patients with permanent atrial fibrillation. Am J Cardiol. 2013;111(2):225-30.
22. SiuCW, Lau CP, Lee WL, Lam KF, TseHF. Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation. Crit Care Med. 2009;37(7):2174-9.
23. Andrade JG, Connolly SJ, Dorian P, Green M, Humphries KH, Klein GJ, et al. Antiarrhythmic use from 1991 to 2007: insightsfrom the Canadian Registry of Atrial Fibrillation (CARAF I and II). Heart Rhythm. 2010;7(9):1171-7.
24. McCabe JM, Johnson CJ, Marcus GM. Internal medicine physicians' perceptions regarding rate versus rhythm control for atrial fibrillation. Am J Cardiol. 2009;103(4):535-9.
25. Kowey PR, Breithardt G, Camm J, Crijns H, Dorian P, Le Heuzey JY, et al. Physician stated atrial fibrillation management in light of treatment guidelines: data from an international, observational prospective survey. ClinCardiol. 2010;33(3):172-8.